cognitive cybersecurity intelligence

News and Analysis


Key Considerations For Cell Gene Therapy Developers To Tap Into AI

Artificial intelligence (AI) and machine learning (ML) have potential to revolutionise cell and gene therapy (CGT), from patient recruitment to supply chain optimisation. Up to 90% of AI/ML models do not make it into production due to challenges in data handling and regulatory hurdles. CGT developers looking to adopt AI must ensure they are aware of these issues and address challenges relating to data availability, limitations in data access, algorithm validation and security.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts